AstraZeneca, Daiichi Sankyo and Summit Therapeutics launch cancer drug collaboration
LONDON: AstraZeneca and Daiichi Sankyo have entered a clinical collaboration agreement with Summit Therapeutics Inc. to test a combination of two cancer drugs across multiple tumor types, including lung and breast cancers, the companies announced. The collaboration will evaluate Datroway,…